[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100465317":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":34,"responsibleParty":162,"collaborators":20,"id":164,"slug":165,"hasResults":166,"nctId":167,"briefTitle":168,"officialTitle":169,"acronym":170,"eligibilityCriteria":171,"healthyVolunteers":166,"sex":172,"minAge":173,"maxAge":20,"enrollmentInfo":174,"targetDuration":20,"studyType":177,"phases":178,"briefSummary":180,"conditions":181,"keywords":20,"overallStatus":51,"whyStopped":20,"lastUpdateSubmitDate":184,"lastUpdatePostDateStruct":185,"startDateStruct":188,"completionDateStruct":190,"leadSponsor":192,"locationsCount":193},{"fullName":5,"class":6},"Fresenius Medical Care North America","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Ci-Ca Arm","EXPERIMENTAL","The study population will include critically ill subjects who are a minimum of 18 years old, in an acute setting, requiring CRRT. the Subjects will receive Regional Citrate Anticoagulation (RCA) which will be delivered by MultiFiltiratePRO system",[13],"Combination Product: Dialysis",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"COMBINATION_PRODUCT","Dialysis","In this study critically ill adult patients requiring Continuous Renal Replacement Therapy (CRRT) will receive Regional Citrate Anticoagulation (CRA) which will be delivered by multiFiltratePRO system.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Manuela Stauss-Grabo, PhD","STUDY_DIRECTOR",[26,31],{"name":27,"role":28,"phone":29,"phoneExt":20,"email":30},"Anja Derlet-Savoia, PhD","CONTACT","+49 173 965 9356","anja.derlet@freseniusmedicalcare.com",{"name":23,"role":28,"phone":32,"phoneExt":20,"email":33},"+49 1525 469 1929","manuela.stauss-grabo1@freseniusmedicalcare.com",[35,49,61,75,90,100,114,124,138,148],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":20},"John L. McClellan Memorial Veterans' Hospital","COMPLETED","Little Rock","Arkansas","72205","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-92.28959,34.74648,{"lat":47,"lon":46},{"facility":50,"status":51,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":52,"geoPoint":54,"contacts":55},"University of Arkansas for Medical Sciences (UAMS)","RECRUITING",{"type":44,"coordinates":53},[46,47],{"lat":47,"lon":46},[56,58],{"name":57,"role":28,"phone":20,"phoneExt":20,"email":20},"Alperdis L Keyes",{"name":59,"role":60,"phone":20,"phoneExt":20,"email":20},"Nithin Karakala","PRINCIPAL_INVESTIGATOR",{"facility":62,"status":63,"city":64,"state":65,"zip":66,"country":41,"countryCode":42,"cosmosGeoPoint":67,"geoPoint":71,"contacts":72},"Advent Health Orlando","NOT_YET_RECRUITING","Orlando","Florida","32803",{"type":44,"coordinates":68},[69,70],-81.37924,28.53834,{"lat":70,"lon":69},[73],{"name":74,"role":60,"phone":20,"phoneExt":20,"email":20},"Arnaldo Lopez Ruiz",{"facility":76,"status":51,"city":77,"state":78,"zip":79,"country":41,"countryCode":42,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"UMass Memorial Medical Center","Worcester","Massachusetts","01655",{"type":44,"coordinates":81},[82,83],-71.80229,42.26259,{"lat":83,"lon":82},[86,88],{"name":87,"role":28,"phone":20,"phoneExt":20,"email":20},"Ann McCarthy",{"name":89,"role":60,"phone":20,"phoneExt":20,"email":20},"Matthew Trainor",{"facility":91,"status":37,"city":92,"state":93,"zip":94,"country":41,"countryCode":42,"cosmosGeoPoint":95,"geoPoint":99,"contacts":20},"University of Michigan","Ann Arbor","Michigan","48109-5000",{"type":44,"coordinates":96},[97,98],-83.74088,42.27756,{"lat":98,"lon":97},{"facility":101,"status":51,"city":102,"state":93,"zip":103,"country":41,"countryCode":42,"cosmosGeoPoint":104,"geoPoint":108,"contacts":109},"Henry Ford Hospital","Detroit","48202",{"type":44,"coordinates":105},[106,107],-83.04575,42.33143,{"lat":107,"lon":106},[110,112],{"name":111,"role":28,"phone":20,"phoneExt":20,"email":20},"Emmy Abraham",{"name":113,"role":60,"phone":20,"phoneExt":20,"email":20},"Junior Uduman",{"facility":115,"status":37,"city":116,"state":117,"zip":118,"country":41,"countryCode":42,"cosmosGeoPoint":119,"geoPoint":123,"contacts":20},"Mayo Clinic","Rochester","Minnesota","55905",{"type":44,"coordinates":120},[121,122],-92.4699,44.02163,{"lat":122,"lon":121},{"facility":125,"status":51,"city":126,"state":127,"zip":128,"country":41,"countryCode":42,"cosmosGeoPoint":129,"geoPoint":133,"contacts":134},"University of Mississippi Medical Center","Jackson","Mississippi","39350",{"type":44,"coordinates":130},[131,132],-90.18481,32.29876,{"lat":132,"lon":131},[135,137],{"name":136,"role":28,"phone":20,"phoneExt":20,"email":20},"Catherine Wells",{"name":136,"role":60,"phone":20,"phoneExt":20,"email":20},{"facility":139,"status":37,"city":140,"state":141,"zip":142,"country":41,"countryCode":42,"cosmosGeoPoint":143,"geoPoint":147,"contacts":20},"Washington University - Hospital","St Louis","Missouri","63110",{"type":44,"coordinates":144},[145,146],-90.19789,38.62727,{"lat":146,"lon":145},{"facility":149,"status":51,"city":150,"state":151,"zip":152,"country":41,"countryCode":42,"cosmosGeoPoint":153,"geoPoint":157,"contacts":158},"Intermountain Health","Murray","Utah","84107",{"type":44,"coordinates":154},[155,156],-111.88799,40.66689,{"lat":156,"lon":155},[159,161],{"name":160,"role":28,"phone":20,"phoneExt":20,"email":20},"Anitha Vijayan",{"name":160,"role":60,"phone":20,"phoneExt":20,"email":20},{"type":163,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100465317","phase-3-safety-of-regional-citrate-anticoagulation-sarca-study-100465317",false,"NCT05339139","SAfety of Regional Citrate Anticoagulation (SARCA Study)","An Open-label, Prospective, Multicenter Study to Assess the SAfety of Regional Citrate Anticoagulation Delivered by the multiFiltratePRO System in Adult Patients Requiring Continuous Renal Replacement Therapy (SARCA Study)","SARCA","Inclusion Criteria:\n\n1. Signed informed consent form by\n\n   * The subject or\n   * A legally authorized representative (LAR), if the subject is unable to consent\n2. Adult patients ≥ 18 years old\n3. Diagnosis of AKI or End-Stage Kidney Disease (ESKD) requiring CRRT\n4. Vascular access - Dialysis Catheter with size and location per institutional practice\n\nExclusion Criteria:\n\n1. Metabolic alkalosis as defined by serum bicarbonate greater than 30 mmol\u002FL and arterial pH greater than 7.55\n2. A female who is pregnant or breast feeding\n3. Severe liver disease defined as International Normalized Ratio (INR) greater than 2.0 and total bilirubin greater than 5 mg\u002Fdl, and both aspartate aminotransferase (AST) and alanine aminotransferase (ALT) greater than 3 times upper limit of normal\n4. Subjects currently enrolled in or who have completed any other investigational drug or device study within last 30 days prior to signing informed consent\n5. Previous participation in a similar or the same study.\n6. Subjects already on continuous renal replacement therapy\n7. Subjects with active COVID-19 infection\n8. Subjects cannot tolerate citrate therapy defined as severe liver disease (see exclusion criteria #3), shock with muscle hypoperfusion and known hypersensitivity to citrate","ALL","18 Years",{"count":175,"type":176},50,"ESTIMATED","INTERVENTIONAL",[179],"PHASE3","This is an Open-label, Prospective, Multicenter Study to Assess the SAfety of Regional Citrate Anticoagulation Delivered by the multiFiltratePRO system in Adult Patients Requiring Continuous Renal Replacement Therapy (SARCA Study).",[182,183],"Acute Kidney Injury","ESRD","2025-04-23",{"date":186,"type":187},"2025-04-24","ACTUAL",{"date":189,"type":187},"2023-10-17",{"date":191,"type":176},"2025-07-31",{"name":5,"class":6},10]